(Q44591241)

4 December 2017

title

Weekly treatment with irinotecan, folinic acid and infusional 5-fluorouracil (ILF) in patients with advanced gastric cancer (English)

1 reference

4 December 2017

1 reference

1 reference

1 reference

https://api.crossref.org/works/10.1097/00001813-200309000-00010

12 March 2024

1 reference

https://api.crossref.org/works/10.1097/00001813-200309000-00010

12 March 2024

7

Peter R. Galle

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14501387

12 March 2024

author name string

Markus Moehler

1

1 reference

4 December 2017

Ulrike Haas

2

1 reference

4 December 2017

Juergen Siebler

3

1 reference

4 December 2017

Christoph Schimanski

4

1 reference

4 December 2017

Christian Hertkorn

5

1 reference

4 December 2017

Thomas Hoehler

6

1 reference

4 December 2017

Michael Heike

8

1 reference

4 December 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14501387

12 March 2024

publication date

1 September 2003

1 reference

full work available at URL

4 December 2017

https://journals.lww.com/00001813-200309000-00010

1 reference

https://api.crossref.org/works/10.1097/00001813-200309000-00010

12 March 2024

1 reference

4 December 2017

volume

14

1 reference

4 December 2017

issue

8

1 reference

4 December 2017

page(s)

645-650

1 reference

Chemotherapy of gastric cancer

4 December 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1097/00001813-200309000-00010

Treatment of gastric cancer

12 March 2024

2

1 reference

https://api.crossref.org/works/10.1097/00001813-200309000-00010

Final results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus etoposide, leucovorin, and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer: A trial of the

12 March 2024

3

1 reference

https://api.crossref.org/works/10.1097/00001813-200309000-00010

New drugs for treatment of gastric cancer

12 March 2024

4

1 reference

https://api.crossref.org/works/10.1097/00001813-200309000-00010

Clinical advances with topoisomerase I inhibitors in gastrointestinal malignancies

12 March 2024

5

1 reference

https://api.crossref.org/works/10.1097/00001813-200309000-00010

A phase II study of irinotecan with 5-fluorouracil and leucovorin in patients with previously untreated gastric adenocarcinoma

12 March 2024

8

1 reference

https://api.crossref.org/works/10.1097/00001813-200309000-00010

Phase I-II study of irinotecan hydrochloride combined with cisplatin in patients with advanced gastric cancer

12 March 2024

9

1 reference

https://api.crossref.org/works/10.1097/00001813-200309000-00010

Phase II study of a combination of irinotecan and cisplatin against metastatic gastric cancer

12 March 2024

10

1 reference

https://api.crossref.org/works/10.1097/00001813-200309000-00010

Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group

12 March 2024

11

1 reference

https://api.crossref.org/works/10.1097/00001813-200309000-00010

Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial

12 March 2024

12

1 reference

https://api.crossref.org/works/10.1097/00001813-200309000-00010

Phase I study of a weekly schedule of irinotecan, high-dose leucovorin, and infusional fluorouracil as first-line chemotherapy in patients with advanced colorectal cancer

12 March 2024

13

1 reference

https://api.crossref.org/works/10.1097/00001813-200309000-00010

Irinotecan (CPT-11) high-dose escalation using intensive high-dose loperamide to control diarrhea

12 March 2024

16

1 reference

https://api.crossref.org/works/10.1097/00001813-200309000-00010

Safety and efficacy of outpatient treatment with CPT-11 plus bolus folinic acid/5-fluorouracil as first-line chemotherapy for metastatic colorectal cancer

12 March 2024

17

1 reference

https://api.crossref.org/works/10.1097/00001813-200309000-00010

CPT-11-induced cholinergic effects in cancer patients

12 March 2024

18

1 reference

https://api.crossref.org/works/10.1097/00001813-200309000-00010

12 March 2024

19

13

1

van de Velde

2002

1 reference

https://api.crossref.org/works/10.1097/00001813-200309000-00010

Methods of palliation of esophageal and gastric cancer

12 March 2024

20

1 reference

https://api.crossref.org/works/10.1097/00001813-200309000-00010

Etoposide, folinic acid, and 5-fluorouracil in carboplatin-pretreated patients with advanced gastric cancer

12 March 2024

21

1 reference

https://api.crossref.org/works/10.1097/00001813-200309000-00010

Laparoscopic lymph node assessment in pretherapeutic staging of gastric and esophageal cancer

12 March 2024

22

1 reference

https://api.crossref.org/works/10.1097/00001813-200309000-00010

Prognostic factors for development of peritoneal carcinosis in stomach carcinoma

12 March 2024

23

1 reference

https://api.crossref.org/works/10.1097/00001813-200309000-00010

12 March 2024

Identifiers

1 reference

4 December 2017

1 reference